Philip D. Harvey

Psychiatry and Mental health · 2001–2007

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Psychiatry and Mental health — 13 citations into it
• Philosophy — 6 citations into it

Whom Philip D. Harvey trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Michael F. Green

Who trusts Philip D. Harvey overall

1. R. Keefe
2. R. Mesholam-Gately
3. Peter Mondrup Rasmussen
4. Georg Winterer

Papers from Philip D. Harvey's perspective

Ordered by how strongly the researchers Philip D. Harvey trusts endorse each paper. Same corpus, a different order for every researcher.

1. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. (American Journal of Psychiatry)
2. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. (International Journal of Neuropsychopharmacology)
3. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. (American Journal of Psychiatry)
4. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. (Archives of General Psychiatry)
5. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. (American Journal of Psychiatry)
6. Working memory
7. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. (American Journal of Psychiatry)
8. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. (Biological Psychiatry)
9. Cognition through the lifespan: mechanisms of change. (Trends in Cognitive Sciences)
10. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. (Schizophrenia Research)

Their papers

• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. (2007) — 1,086 citations
• Administration and interpretation of the Trail Making Test (2006) — 1,302 citations
• Cognitive deficits and functional outcome in schizophrenia (2006) — 625 citations
• Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. (2006) — 753 citations
• Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. (2001) — 637 citations